GO
Loading...

CVS Caremark Corp

More

  • UPDATE 2-CVS expects 2014 sales gain despite Obamacare Wednesday, 18 Dec 2013 | 12:50 PM ET

    NEW YORK, Dec 18- CVS Caremark Corp said on Wednesday that it expected sales and earnings to rise in 2014 despite only a "modest" benefit next year from the launch of Obamacare and a ban preventing it from marketing to some Medicare patients.

  • NEW YORK, Dec 18- U.S. stocks were little changed on Wednesday as the market cautiously awaited Federal Reserve's last policy announcement of the year which might determine the immediate future of its current program to stimulate the economy.

  • Midday movers: Ford, General Mills, FedEx & More Wednesday, 18 Dec 2013 | 12:36 PM ET

    Some of Wednesday's midday movers:

  • NEW YORK, Dec 18- U.S. stocks were little changed on Wednesday ahead of the Federal Reserve's last policy announcement of the year, which might determine the immediate future of its current program to stimulate the economy. Fed Chairman Ben Bernanke will follow the announcement with his final news conference at the helm of the U.S. central bank about 2:30 p.m..

  • US STOCKS-Wall Street ticks up, Fed decision awaited Wednesday, 18 Dec 2013 | 10:26 AM ET

    *FedEx results miss Wall Street estimates, shares dip. *Lennar shares up after results; Jabil slides on outlook. Fed Chairman Ben Bernanke will follow the 2:00 p.m. EST announcement with his final press conference at the helm of the U.S. central bank at 2:30 p.m..

  • Dec 18- CVS Caremark Corp said on Wednesday that it expected sales and earnings to rise in 2014 even though it anticipated only a "modest" benefit next year from the launch of the U.S.

  • CVS expects 2014 earnings to rise, lifts dividend Wednesday, 18 Dec 2013 | 7:39 AM ET

    Dec 18- CVS Caremark Corp said on Wednesday that it expected adjusted earnings to rise to a range of $4.36 to $4.50 per share in 2014.. The drugstore operator and pharmacy benefits manager said its board had approved a 22 percent increase in the quarterly dividend, bringing it up to 27.5 cents per share. The board also approved a new $6 billion share buyback program.

  • *Cardinal Health, CVS rise after JV announcement. *Rambus rallies after settling with Micron. There's no reason to think this is anything different than that, "said Paul Zemsky, head of asset allocation at ING Investment Management in New York.

  • Midday movers: Starbucks, Twitter, PVH & More Tuesday, 10 Dec 2013 | 1:23 PM ET

    Some of Tuesday's midday movers:

  • Dec 10- Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc on Tuesday announced a 10- year agreement to form the largest generic drug sourcing operation in the United States, the world's biggest generic drug market.

  • Dec 10- Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc said on Tuesday they would form the largest U.S. generic drug sourcing operation in a 10- year agreement to serve the world's biggest market for generic drugs. The 50-50 joint venture will be operational as soon as July 1, 2014.

  • Cramer: ‘I’m throwing up my hands with this group’ Wednesday, 4 Dec 2013 | 11:16 AM ET

    Muddled by inconsistent earnings and stock performances, one sector appears tougher and tougher to predict, CNBC's Jim Cramer says.

  • Early movers: KKD, POT, AAPL, TSLA & more Tuesday, 3 Dec 2013 | 7:50 AM ET

    Some of the names on the move ahead of the open.

  • The Nasdaq got a boost from the technology sector, with Apple up 1.9 percent at $556.07, Microsoft Corp up 1.4 percent at $38.13 and Amazon Inc up 1.8 percent at $393.62. We wouldn't be shocked at all to see the small and mid-cap names lag a little bit, "said Ryan Detrick, senior technical strategist with Schaeffer's Investment Research, in Cincinnati.

  • US STOCKS-Wall St gains in brief post-holiday session Friday, 29 Nov 2013 | 12:05 PM ET

    *Markets closing at 1 p.m.; volume expected to be light. NEW YORK, Nov 29- U.S. stocks rose modestly on Friday, with investors wary of making big bets in a short post-holiday session, though the S&P 500 is set for its longest weekly winning streak in 10 years.

  • Nov 27- CVS Caremark Corp will buy drug infusion services provider Coram LLC for $2.1 billion, allowing the company to bolster its pharmacy benefits management business by offering cost-effective delivery of specialty drugs.

  • Nov 27- CVS Caremark Corp said on Wednesday it was buying Coram LLC, Apria Healthcare Group Inc's specialty infusion services and enteral nutrition business unit, for $2.1 billion.

  • Nov 27- CVS Caremark Corp said on Wednesday it was buying Coram LLC, Apria Healthcare Group Inc's specialty infusion services and enteral nutrition business unit, for $2.1 billion.

  • Your first trade for Wednesday Tuesday, 26 Nov 2013 | 1:08 PM ET

    The "Fast Money" traders share their final trades of the day.

  • One man, one small business, four billionaires Wednesday, 13 Nov 2013 | 8:00 AM ET

    An entrepreneur has attracted investments from four billionaires: Sam Zell, Herb Simon, David Bonderman and "one family you've never heard of."

Most Popular Video

Thursday, 24 Apr 2014 | 8:49 AM ET

Today CNBC's Jim Cramer explains why he wishes his charitable trust owned shares of Caterpillar, and shares his thoughts on the government's inability to create jobs.

Thursday, 24 Apr 2014 | 8:16 AM ET

Daniel Ernst, Hudson Square Research, provides perspective on Apple's earnings and growth potential. Apple is really innovating but they haven't done it in three years, Ernst says.

Thursday, 24 Apr 2014 | 8:02 AM ET

Doug Oberhelman, Caterpillar chairman & CEO, digs deep into the company's first quarter results and shares his outlook on global sales. CAT reported EPS of $1.44 on revenues of $13.24 billion, beating on both the top and bottom line.